Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression
May 20, 2013
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.
Mount Sinai Experts Call for Research on Prevalence of Delayed Neurological Dysfunction After Head Injury
April 5, 2013
Preventive measures, genetic risks, new diagnostic tools needed to identify effects of traumatic brain injury in athletes, soldiers.
Mount Sinai Leads Global Program Using Stem Cells to Accelerate Cures for Alzheimer's Disease
March 27, 2013
Researchers collaborate with the New York Stem Cell Foundation using skin samples and brain imaging to identify causes and cures.
New Drug Is Safe and Effective in Reducing 'Off' Time in People with Parkinson's Disease
March 21, 2013
New research in Parkinson's disease and Alzheimer's disease were presented at the American Academy of Neurology meeting this week.
Mount Sinai Establishes New Pediatric Program for Mood and Anxiety Disorders
February 20, 2013
Mount Sinai has established a new Pediatric Mood and Anxiety Program to help address the public health crisis of mental illness in children.
Mount Sinai Opens New Center for Tic and Obsessive-Compulsive Disorders
January 24, 2013
New Division of Tic and Obsessive-Compulsive and Related Disorders (DTOR) Aligns with New Category in the Diagnostic and Statistical Manual
Facts about How Mount Sinai is Researching and Treating Brain Diseases
December 14, 2012
The Mount Sinai Medical Center is one of the world’s leading institutions in discovering better ways to prevent, diagnose, and treat serious brain diseases.
Short DNA Strands in the Genome May be Key to Understanding Human Cognition and Diseases
November 20, 2012
Previously discarded, human-specific “junk” DNA represents untapped resource in the study of diseases like Alzheimer’s and autism
National Institutes of Health Awards $100 million for Autism Centers of Excellence Program
October 15, 2012
Mount Sinai School of Medicine is one of nine grantees to receive research funding over next five years.
Mount Sinai Researcher Receives Prestigious National Institutes of Health Award
September 13, 2012
Anne Schaefer, MD, PhD, Assistant Professor of Neuroscience and Psychiatry, has been recognized with the Director's New Innovator Award.
EurekAlert.com - "Rejected Drug May Protect Against Toxic Substance Common to Both Alzheimer’s and Parkinson’s Diseases"
August 13, 2012
Latrepirdine, which failed in U.S. Clinical Trials of Alzheimer’s Disease, is showing new potential in an animal model.
Researchers Rediscover Potential of Rejected Alzheimer’s Drug to Arrest Progression of Disease in Mice
August 8, 2012
Study Suggests that Latrepirdine, Which Previously Failed in Clinical Trials, May Be Successful if Tested on Patients with Earlier Stages of the Disease
Wayne Goodman, MD, Receives Career Achievement Award from International OCD Foundation
July 28, 2012
The honor was presented to Dr. Goodman at the 19th Annual International OCD Foundation Conference in Chicago.
Mount Sinai Researcher Finds Common Factors in Autism Spectrum Disorders, Schizophrenia, and Bipolar Disorder
July 2, 2012
The study was published online by Archives of General Psychiatry on Monday, July 2.
Mount Sinai Researcher Receives Career-Starter Research Grant for 2012-2013
June 20, 2012
Hirofumi Morishita, MD, PhD, receives a Career-Starter Research Grant for 2012-2013 from the Knights Templar Eye Foundation.
New Clinical Study Evaluates First Drug to Show Improvement in Subtype of Autism
April 24, 2012
Mount Sinai School of Medicine undertakes a clinical trial to evaluate insulin-like growth factor in children who have SHANK3 deficiency, a known cause of autism spectrum disorder.
Mutations in Three Genes Linked to Autism Spectrum Disorders
April 4, 2012
Mount Sinai's findings, as part of a trio of papers revealing new genetic targets in autism, are published in the April 4th online issue of the journal Nature.
Leo Sher, MD, named to a World Psychiatric Association Scientific Section
March 8, 2012
In his new role, Dr. Sher will participate in multiple academic activities of the World Psychiatric Association.
Decaffeinated Coffee Improves Brain Energy Metabolism in an Animal Study
February 2, 2012
Mount Sinai researchers have found that decaffeinated coffee may reduce impaired brain energy metabolism associated with type 2 diabetes, a known risk factor for neurocognitive disorders.
Maternal Type 2 Diabetes and Low Income Significantly Increase Risk for ADHD in Children
January 2, 2012
Mount Sinai researchers have found that low socioeconomic status and gestational diabetes together increase the risk of ADHD in children 14-fold.
Mary V. Solanto, PhD, Receives Award for Innovative Program Treating Adults with ADHD
December 12, 2011
Dr. Solanto was recognized by Children and Adults with ADHD for a new program using cognitive behavioral therapy to improve executive function in people with ADHD.
Researchers Discover Clues to Developing More Effective Antipsychotic Drugs
November 23, 2011
Mount Sinai has identified the pattern of cell signaling induced by antipsychotic drugs in a complex composed of two brain receptors linked to schizophrenia.
Several Common Genetic Variants Found to be Associated With Mental Illness
September 20, 2011
New findings represent a significant advance in understanding the causes of schizophrenia and bipolar disorder.
Researchers Find Novel Drug Target for the Treatment of Post-Traumatic Stress Disorder (PTSD)
September 6, 2011
Alexander Neumeister, MD, Associate Professor of Psychiatry, has identified a promising therapeutic target in the brain that could lead to the treatment of PTSD.
Gene that Causes Type 2 Diabetes May Also Cause Alzheimer’s
July 18, 2011
Researchers have found that a gene that causes diabetes kills nerve cells in the brain, possibly resulting in Alzheimer’s disease.
New Research Shows the Aging Brain Does Not Respond To Experience As Well as the Younger Brain
May 24, 2011
Mount Sinai researchers have found reduced ability of the aging brain to learn and respond to experiences, a finding that sheds new light on the aging process.
Larry J. Siever, MD, Recognized by His Peers for Contributions to Personality Disorders Research
May 17, 2011
Dr. Siever was honored with the Judd Marmor Award Lecture at the American Psychiatric Association meeting in Honolulu.
Mount Sinai Starts New Division of Psychiatric Genomics to Understand Genetics Behind Psychiatric Disorders
May 13, 2011
Pamela Sklar, MD, PhD, a distinguished researcher of genetics in mental illness, has joined Mount Sinai to found the Division of Psychiatric Genomics.
Consortium of Researchers Identify Four New Genes Linked to Alzheimer’s Disease Risk
April 3, 2011
A consortium of researchers has identified four new genes that when present increase the risk of a person developing Alzheimer’s disease later in life.
Indications of Alzheimer’s Disease May Be Evident Decades Before First Signs of Cognitive Impairment
March 28, 2011
Mount Sinai Researchers find a link between lower glucose utilization in the brain and Alzheimer’s disease.
Mount Sinai Launches Neuroimaging Study to Understand Brain Changes in Alzheimer’s Disease
March 8, 2011
Funded by the NIH, the study will use imaging techniques and biomarkers to understand changes in the structure and function of the brain.
Four Mount Sinai Researchers Awarded Prestigious "Young Investigator Grant" for Their Brain and Behavior Research
February 18, 2011
The National Alliance for Research on Schizophrenia and Depression awarded the $60,000 grants to enable the scientists to continue their work.
Mount Sinai Welcomes Pamela Sklar, MD, PhD
January 31, 2011
Following a national search, the Mount Sinai School of Medicine Department of Psychiatry has recruited Dr. Sklar as the founding Chief of its Division of Psychiatric Genomics.
Mount Sinai Researchers Find That Little-Studied Gene May Boost Long-Term Memory and Enhance Cognition
January 26, 2011
Treatment with a gene called IGF-II significantly improved long-term memory. When the gene was blocked, long-term memories could not form.
Mount Sinai Researchers Learn Mechanism Behind Genetic Mutation Associated with Autism
December 17, 2010
Research shows that when a copy of a certain gene is missing, nerve cells do not effectively communicate, leading to some autism spectrum disorders.
Hormone Oxytocin, Delivered Nasally, Intensifies Positive and Negative Memories of Mom
November 29, 2010
Mount Sinai researchers find that oxytocin enhances men's positive or negative recollections of their mother's affection during childhood.
Mount Sinai Hosts Prestigious Clinical Practicum in Autism with Keynote from Eustacia Cutler
November 3, 2010
The American Academy of Child & Adolescent Psychiatry selected the Seaver Autism Center for Research & Treatment to host a clinical practicum on autism research.
New Mount Sinai Program Seeks to Overcome Mental Health Barriers in City Kids
October 20, 2010
The NIH has awarded Mount Sinai School of Medicine $4.2 million to lead a new initiative addressing mental health concerns of city children and their families.
Gene Associated with Type 2 Diabetes Is Low in People with Alzheimer’s Disease
October 12, 2010
A study in the journal Aging Cell shows that people with Alzheimer’s disease have a low level of the gene PGC-1, which regulates glucose.
Mount Sinai Researcher Awarded Renowned Institute of Medicine Prize for Outstanding Achievements in Improving Mental Health
October 11, 2010
Dr. Eric Nestler honored for his work and achievements in addiction science.
Mount Sinai Researchers Identify Key Mechanism in Gene Linking Diabetes to Alzheimer’s
September 28, 2010
Dr. Sam Gandy and his team have found that that a gene for a protein that may cause type 2 diabetes impacts the development of Alzheimer’s disease.
Mount Sinai Study Shows That Major Alzheimer’s Risk Gene Causes Alterations in Shapes of Brain Protein Deposits
July 14, 2010
A team led by Dr. Sam Gandy is presenting new research at the Alzheimer's Association International Conference on Alzheimer's Disease
Mount Sinai Honors Female Scientists with Inaugural Robin Chemers Neustein Postdoctoral Fellowship
June 30, 2010
Inaugural award supporting female scientists at Mount Sinai School of Medicine has been awarded to Molly A. Ingersoll, PhD, and Ruth I. Johnson, PhD.
New York Magazine Names 18 Department of Psychiatry Physicians as "Best Doctors"
June 23, 2010
Each year, New York Magazine pares down the list of Top Doctors: New York Metro Area, prepared by Castle Connolly Medical Ltd. to create New York Magazine's "Best Doctors" list. Year after year, Department of Psychiatry faculties appear in the issue.
Center of Excellence for OCD and Related Disorders Announces Its Opening
June 1, 2010
The Center treats severe obsessive-compulsive disorders and offers comprehensive evaluations, consultations, and innovative and evidence-based treatments.
Dan Iosifescu, MD, Named Director of the Mood and Anxiety Disorders Program at Mount Sinai School of Medicine
May 14, 2010
Dan Iosifescu, MD, is named Director of the Mood and Anxiety Disorders Program and Associate Professor of Psychiatry and Neuroscience.
Mount Sinai Invites Local Families to Learn About Research Breakthroughs in Mental Illness
April 30, 2010
Research breakthroughs in mental illness will be among the topics discussed at a Mount Sinai community forum on Saturday, May 1.
Wayne K. Goodman, MD, Honored with Mysell Lecture By Harvard Medical School
March 24, 2010
Wayne K. Goodman, MD, Chair of the Department of Psychiatry at Mount Sinai, has been selected to deliver the prestigious Mysell Lecture at Harvard.
The Mount Sinai Medical Center Teams With NFL to Create Neurological Program for Retired Players
March 24, 2010
The NFL has selected The Mount Sinai Medical Center to be part of its new Neurological Care Program (NCP) for retired NFL players.
Joanna Fowler, PhD, Receives Nation's Highest Honor for Outstanding Achievement in Science
October 7, 2009
Dr. Fowler, Professor of Psychiatry at Mount Sinai School of Medicine and Senior Scientist at Brookhaven National Laboratory, received the National Medal of Science.
Mount Sinai Research Identifies Brain Mechanisms Associated with Borderline Personality Disorder
September 3, 2009
Through real-time imaging, researchers have collected evidence to suggest that neurological networks that help regulate emotion do not activate in patients with borderline personality disorder.
Mount Sinai School of Medicine Significantly Improves Its U.S. News & World Report Best Graduate Schools Rankings
April 24, 2009
Over the past four years, Mount Sinai has improved in the U.S. News & World Report "America's Best Graduate Schools" rankings more than any other school in the United States, jumping from 32nd to 22nd.
New Psychiatric Program at The Mount Sinai Medical Center Addresses Special Needs of Multiple Sclerosis Patients
February 26, 2009
The new program provides for an on-site psychiatrist to assist in the identification and management of psychiatric and psychological disorders in patients with MS, including depression.
Icahn School of Medicine Department of Psychiatry